Evidence map›Paper›PMID 42390607›Full record

ArticleJournal of neurology2026

Brain-first versus body-first Parkinson's disease: Differential findings on pupillary, brainstem and vagus sonography.

Uwe Walter, Michael Batchakaschvili, Hanna Rebekka Kleinlein, Jakub Radziwon, Wiebke Hermann, Hartmut Walter, Alexander Storch, Matthias Löhle

Abstract read
In one paragraph

Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Uwe WalterDepartment of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany. uwe.walter@med.uni-rostock.de.ORCID http://orcid.org/0000-0002-6280-785X
Michael BatchakaschviliDepartment of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.
Hanna Rebekka KleinleinDepartment of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.
Jakub RadziwonDepartment of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.ORCID http://orcid.org/0000-0001-6046-7057
Wiebke HermannDepartment of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.ORCID http://orcid.org/0000-0001-9266-9673
Hartmut Walter *Department of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.
Alexander StorchDepartment of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.ORCID http://orcid.org/0000-0002-1133-9216
Matthias LöhleDepartment of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.ORCID http://orcid.org/0000-0002-0645-0825

Funding

European Academy of Neurology EAN Student Teaser Fellowship 2022European Regional Development Fund GHS-15-0017European Regional Development Fund GHS-23-0045
6 · The paper itself

Abstract

backgroundIn Parkinson's disease (PD), two pathogenetic subtypes have been proposed: a 'brain-first', with α-synuclein pathology arising in one hemisphere and spreading secondarily to the peripheral autonomic nervous system, and a 'body-first' subtype, with the pathology originating in the enteric or peripheral autonomic nervous system and subsequently spreading symmetrically to the brain. To dissect these subtypes, we assessed the association between pupillary dysfunction, mesencephalic raphe and substantia nigra changes, vagus nerve atrophy and vagal electrocardiographic parameters in PD patients and controls.

methodsIn this single-center cross-sectional study, we included 54 people with PD and 60 matched healthy controls. Participants underwent clinical assessments, electrocardiography, and sonographic measurements of substantia nigra echoic area, midbrain raphe echo-score and vagus nerve caliber. Dynamic ultrasound pupillometry was performed in drug-naïve de novo PD patients and matched controls. The brain-first and body-first subtypes were classified based on the REM-sleep Behavior Disorder Screening Questionnaire and gastrointestinal symptoms.

resultsVagal atrophy increased with disease duration and severity. During the first decade of motor disease, vagal atrophy and dysfunction occurred in body-first but not brain-first PD. Sympathetic pupillary innervation was reduced in de novo body-first but not brain-first PD patients. However, parasympathetic pupillary innervation was reduced in both subtypes at the de novo stage. Substantia nigra hyperechoic area was asymmetrical in brain-first but more symmetrical in body-first PD.

conclusionsOur findings support the concept of two subtypes of PD in which the mesencephalic and vagal parasympathetic systems are affected in opposite sequences. Ultrasonic and electrocardiographic examination could facilitate early subtyping.

Indexed as

Brain StemParkinson DiseaseVagus NerveAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedUltrasonographyParkinson’s diseasePupillary reflexSubstantia nigraTranscranial ultrasoundUltrasonographyVagus nerve

Identifiers

PMID42390607
PMCPMC13328145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.